| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
46,601 |
42,702 |
$1.51M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
29,363 |
27,045 |
$1.16M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
25,905 |
10,215 |
$468K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
3,095 |
2,826 |
$210K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
3,415 |
3,187 |
$108K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,188 |
2,062 |
$101K |
| 99222 |
Initial hospital care, per day, moderate complexity |
2,508 |
2,314 |
$92K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
7,001 |
3,080 |
$89K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
3,085 |
2,978 |
$88K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,529 |
2,460 |
$73K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
2,330 |
2,127 |
$59K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
396 |
357 |
$45K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,648 |
3,443 |
$37K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
624 |
584 |
$37K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
599 |
572 |
$30K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
472 |
467 |
$27K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,273 |
3,139 |
$25K |
| 99223 |
Prolong inpt eval add15 m |
449 |
432 |
$20K |
| 90837 |
Psychotherapy, 53 minutes with patient |
354 |
157 |
$18K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
713 |
671 |
$16K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
197 |
183 |
$15K |
| 20610 |
|
422 |
350 |
$14K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
412 |
385 |
$13K |
| 99215 |
Prolong outpt/office vis |
384 |
354 |
$13K |
| 87428 |
|
463 |
428 |
$13K |
| 99233 |
Prolong inpt eval add15 m |
746 |
322 |
$12K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
70 |
69 |
$12K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,674 |
1,483 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
838 |
501 |
$11K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
174 |
169 |
$10K |
| 99221 |
|
316 |
290 |
$8K |
| 95251 |
|
1,087 |
999 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
656 |
566 |
$8K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
111 |
110 |
$7K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
49 |
47 |
$6K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
836 |
689 |
$6K |
| 99177 |
|
591 |
581 |
$5K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
28 |
27 |
$5K |
| 80305 |
|
608 |
556 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
66 |
64 |
$4K |
| 90966 |
|
104 |
95 |
$3K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
12 |
12 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
523 |
493 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
60 |
59 |
$3K |
| 80061 |
Lipid panel |
249 |
240 |
$3K |
| 43235 |
|
29 |
29 |
$2K |
| 94060 |
|
275 |
264 |
$2K |
| 99152 |
|
430 |
339 |
$2K |
| 90961 |
|
93 |
90 |
$2K |
| 92551 |
|
328 |
318 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
395 |
367 |
$2K |
| 95811 |
|
25 |
24 |
$1K |
| 27096 |
|
26 |
25 |
$1K |
| 64493 |
|
40 |
32 |
$1K |
| 64635 |
|
68 |
49 |
$1K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
15 |
15 |
$1K |
| 92558 |
|
62 |
62 |
$1K |
| 94726 |
|
288 |
277 |
$955.35 |
| 94729 |
|
295 |
284 |
$858.79 |
| 82962 |
|
397 |
376 |
$715.28 |
| 90870 |
|
33 |
14 |
$631.02 |
| 64494 |
|
37 |
30 |
$600.45 |
| 93000 |
|
59 |
50 |
$578.70 |
| 99225 |
|
41 |
25 |
$508.02 |
| 64495 |
|
32 |
26 |
$504.73 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
65 |
57 |
$430.35 |
| 99406 |
|
96 |
89 |
$407.43 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
30 |
29 |
$406.00 |
| 90688 |
|
29 |
29 |
$393.56 |
| 87807 |
|
37 |
36 |
$317.03 |
| 36415 |
Collection of venous blood by venipuncture |
147 |
142 |
$282.37 |
| 99306 |
Prolong nursin fac eval 15m |
15 |
12 |
$228.41 |
| 81025 |
|
45 |
38 |
$222.67 |
| 99305 |
|
28 |
18 |
$202.86 |
| 81002 |
|
104 |
94 |
$201.98 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$194.08 |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
28 |
15 |
$173.35 |
| 73560 |
|
35 |
27 |
$141.14 |
| 99441 |
|
15 |
12 |
$138.59 |
| 1036F |
|
3,653 |
3,298 |
$0.00 |
| 3044F |
|
696 |
665 |
$0.00 |
| 3008F |
|
4,324 |
3,953 |
$0.00 |
| 99072 |
|
2,185 |
2,122 |
$0.00 |
| 4004F |
|
619 |
557 |
$0.00 |